Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma. (Q43267004)
Jump to navigation
Jump to search
scientific article published on 25 September 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma. |
scientific article published on 25 September 2009 |
Statements
Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma (English)
Jo Thompson-Coon
Colin Green
Zulian Liu
Karen Welch
Tiffany Moxham
25 September 2009